Medicines Optimisation

Following a process of stakeholder engagement and due diligence to provide the necessary assurances and clinical specifications, the CCG in the North East of England commissioned a review of 6 clinical areas, incorporating a formulary review of 16 therapies within:

  • Mental health
  • Oral contraception
  • Dermatology
  • Pen needles
  • Oral Nutritional supplements
  • Ulcerative colitis

MMS® worked in collaboration with commissioning groups and pharma industry to support a QIPP plan and provide both significant and tangible outcomes.

Screen Shot 2019-03-31 at 16.54.17


£425,100 total annualised savings